New Zealand markets closed

Context Therapeutics Inc. (CNTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0000-0.0600 (-2.91%)
At close: 04:00PM EDT
1.9800 -0.02 (-1.00%)
Pre-market: 04:07AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.0600
Open2.0100
Bid0.0000 x 800
Ask0.0000 x 1300
Day's range1.9300 - 2.0700
52-week range1.2700 - 10.8700
Volume305,828
Avg. volume376,935
Market cap31.932M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.9300
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Is Context Therapeutics (NASDAQ:CNTX) In A Good Position To Deliver On Growth Plans?

    Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

  • GlobeNewswire

    Context Therapeutics® Reports First Quarter 2022 Operating and Financial Results

    Abstract on results of the monotherapy portion of Phase 2 ONA-XR clinical trial in granulosa cell tumors of the ovary accepted for oral presentation at the 2022 ASCO Annual Meeting Preclinical data presented at AACR Annual Meeting showcased potential of ONA-XR and CLDN6xCD3 bispecific development program PHILADELPHIA, May 11, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treat

  • GlobeNewswire

    Context Therapeutics® Announces Poster Presentation at the Upcoming 2022 ASCO Annual Meeting

    Lead clinical-stage oral progesterone receptor (PR) antagonist ONA-XR demonstrates monotherapy clinical activity in advanced granulosa cell tumor of the ovary Trial advanced to second stage to evaluate combination of ONA-XR with oral antiestrogen PHILADELPHIA, May 05, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced